Clinical Trials Browser

Expanded_access × Glioblastoma × Dermatologic × Clear all

NCT04566393 2026-01-28

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

CNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT04289155 2022-03-17

Individual Patient Compassionate Use of GX-I7

No longer available

CNSDermatologic

Glioblastoma, Glioma, Melanoma

NCT03311542 2018-01-10

Expanded Access for Pembrolizumab (MK-3475)

No longer available

CNSDermatologic

Glioblastoma, Glioma, Melanoma